Hint mode is switched on Switch off

XDNA - iShares Genomics Immunology and Healthcare Index ETF (CAD) (CA46437W1059)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.

Choose all Reset all
 
(%)
CA46437W1059
XDNA ISIN
Exchange Traded Funds (ETF)
Type of fund
BlackRock
Provider
-
NAV per Share
26/04/2022
Inception Date
2 times per year
Dividend payments
CEOJLU
CFI
XDNA
Ticker
Formed
Status
Equity
Investment category
Healthcare
Sector
Global
Investor locations
NYSE FactSet Global Genomics and Immuno Biopharma Index
Benchmark
0.39 %
Total Cost Ratio
Physical
Replication method
7.37 mln CAD
Fund NAV | 05/06/2026
7.37 mln CAD
Share Class NAV | 05/06/2026
No
UCITS

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Yield on 04/06/2026, Toronto SE

  • YTD
    9.51 %
  • 1M
    -7.03 %
  • 3M
    0.05 %
  • 6M
    9.54 %
  • 1Y
    46.69 %
  • 3Y
    21.12 %
  • 5Y
    -
  • 10Y
    -
At the price on the exchange, taking into account income payments

Latest data on
Add to compare
from
to
ADD-IN
Cbonds add-in API
bond data api

Quotes (XDNA)

Explore the most comprehensive database

1 000 000

bonds

80 234

stocks

167 970

ETF & Funds

70 000

indices

Track your portfolio in the most efficient way

  • Bond Search
  • Watchlist
  • Excel ADD-IN
Get access
×

— Are you looking for the complete & verified bond data?

— We have everything you need:

full data on over 900 000 bonds, 80 000 stocks, 116 000 ETF & Funds; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.

Register
×

Why

You will have detailed descriptive & pricing data for 650K bonds, 76K stocks, 8K ETFs
Get full access to the platform from any device & via Cbonds app
Enhance your portfolio management with Cbonds Excel Add-in
Build yield maps, make chart comparison within a click
Don't wait any longer — start using Cbonds today! Register

Price dynamics

Fund profile

The iShares Genomics Immunology and Healthcare Index ETF seeks to replicate as close as possible the price and yield performance of the NYSE FactSet Global Genomics and Immuno Biopharma Index composed of companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering.

XDNA profile

The iShares Genomics Immunology and Healthcare Index ETF (CAD) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Healthcare sector located in Global. The BlackRock fund’s base currency is CAD and the share class was registered 26.04.2022 with unique ISIN - CA46437W1059. Main exchange is Toronto SE and ticker symbol is XDNA. The total expense ratio is 0.39%. The iShares Genomics Immunology and Healthcare Index ETF (CAD) pays dividends 2 time(s) per year.

Structure XDNA on 04/06/2026

Download structure in Excel
Paper Value
REVOLUTION MEDICINES INC 7.32%
MODERNA INC 6.97%
IPSEN SA 4.73%
TWIST BIOSCIENCE CORP 4.73%
MERCK & CO INC 4.51%
EXELIXIS INC 4.42%
BAYER AG 3.99%
ROCHE PS PAR AG 3.98%
GLAXOSMITHKLINE 3.97%
TAKEDA PHARMACEUTICAL LTD 3.97%
INCYTE CORP 3.7%
VERTEX PHARMACEUTICALS INC 3.64%
BIONTECH SE ADR 3.48%
SANOFI SA 3.36%
REGENERON PHARMACEUTICALS INC 3.28%
GENMAB 2.91%
IDEAYA BIOSCIENCES INC 2.69%
IMMUNITYBIO INC 2.65%
CARIS LIFE SCIENCES INC 2.19%
ARCUS BIOSCIENCES INC 2.02%
CRISPR THERAPEUTICS AG 1.94%
ONO PHARMACEUTICAL LTD 1.82%
NOVAVAX INC 1.67%
ABCELLERA BIOLOGICS INC 1.61%
IOVANCE BIOTHERAPEUTICS INC 1.6%
NUVATION BIO INC CLASS A 1.35%
VIR BIOTECHNOLOGY INC 0.94%
JANUX THERAPEUTICS INC 0.81%
KURA ONCOLOGY INC 0.81%
GENFLEET THERAPEUTICS (SHANGHAI) I 0.79%
CORVUS PHARMACEUTICALS INC 0.73%
PERSONALIS INC 0.7%
INTELLIA THERAPEUTICS INC 0.6%
RIGEL PHARMACEUTICALS INC 0.58%
SUNSHINE LAKE PHARMA LTD CLASS H 0.53%
PACIFIC BIOSCIENCES OF CALIFORNIA 0.48%
OCUGEN INC 0.46%
VALNEVA 0.45%
CYTOMX THERAPEUTICS INC 0.44%
ALVOTECH SA 0.43%
GINKGO BIOWORKS HOLDINGS INC CLASS 0.42%
SHANGHAI HENLIUS BIOTECH INC H 0.4%
DESIGN THERAPEUTICS INC 0.37%
ABCLON INC 0.37%
XENCOR INC 0.3%
VERASTEM INC 0.28%
PRIME MEDICINE INC 0.12%
CAD CASH 0.11%
GUANGZHOU INNOGEN PHARMACEUTICAL G 0.09%
JPY CASH 0.08%
EUR CASH 0.06%
MEREO BIOPHARMA GROUP ADR REPRESEN 0.05%
GBP CASH 0.05%
CHF CASH 0.01%
USD CASH 0.01%
KRW CASH 0.01%
DKK CASH 0%
ARCELLX INC CVR 0%
TWD CASH 0%
HKD CASH 0%
OMNIAB INC $12.50 VESTING Prvt 0%
OMNIAB INC $15.00 VESTING Prvt 0%
Show more Hide
Other - %

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Other ETF & Funds from this provider

Similar ETF & Funds

  • {{ item.etf.ttl }}
    {{ item.nav_usd }} mln
    NAV
    {{ item.expense_ratio }}
    Total Cost Ratio
Registration is required to get access.